Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Hepatitis C - A Natural Cures Approach Posted By : Dr. James Chappell
Occasionally one of my patients will learn from a blood test that they have contracted Hepatitis C, a "new" disease, barely 20 years old since it was first identified. They often react with surprise and alarm and find themselves completely in the dark

Natalie Cole says she has hepatitis C
Grammy-winning singer Natalie Cole has been diagnosed with hepatitis C, her publicist said in a statement Wednesday. Hepatitis C is a liver disease spread through contact with infected blood. The statement said the disease was revealed during a routine

Hepatitis - Scientists at Shinshu University, Medical Department discuss research in hepatitis
According to recent research from Matsumoto, Japan, 'Autoimmune (AIH) is an organ-specific characterized by of the . Although the HLA DR4 is associated with type 1 AIH in Japanese, the exact of AIH remains undefined.' 'The 4 (CTLA4) is an

UPDATES AND COMMENTARY RSS Feed

Hep C and Fatty Liver Disease Linked by Enzyme
Pittsburgh researchers have found that an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver...

ANA773 Resumes Race Against Hepatitis C
By reducing the dosing schedule in half, Anadys Pharmaceuticals returns to their investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load...

Popular Illegal Drug Extra Harmful with HCV
Although scores of Americans are turning to the street drug methamphetamine to keep them awake and thin, scientists have found that it worsens Hepatitis C infection in two worrisome ways....

Hepatogastroenterology 1998 Jan;45(19):160-169

Liver damage score--a new index for evaluation of the severity of chronic liver diseases.

Krastev Z

Clinic of Gastroenterology, University Hospital St. Ivan Rilsky, Medical University, Sofia.

BACKGROUND/AIMS:

Many hepatologists believe that the Child's classification is not the ultimate prognostic tool for liver disease. Our aim was to develop an index for the estimation of the severity of liver damage, to evaluate its predictive power for the short-term and long-term prognosis of patients with chronic liver disease, and for the estimation of the effect of different therapeutic regimens.

METHODOLOGY:

The Liver Damage Score (LDS) was developed based on the analysis of the laboratory data of 151 randomly selected patients with liver diseases. Variables for reduced protein synthesis, increased production of antibodies, cytolysis, cholestasis, functional renal failure were combined into LDS according to the results of cluster analysis. The evaluation of the liver injury was analyzed in 696 patients with different liver diseases.

RESULTS:

There are three groups of liver diseases: mild-with LDS of 1-2 U, moderate with LDS 3-4.5 U and severe with LDS > 5.0 U. There was a good correlation between the LDS and the scores for liver cirrhosis. Values above 4-6 U carry bad prognosis. The LDS truthfully reflects the evolution of liver diseases over time and the effect of therapy.

CONCLUSION:

The LDS is a new, simple, low-cost, biomathematically and pathophysiologically based index, useful for monitoring practically all patients with liver diseases, no matter what the etiology and stage of the liver injury is. It allows a quantitative expression of the disease severity and the improvement or deterioration in its course.

PMID: 9496507, UI: 98157592

Table Of Contents

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 20 Jul 2008